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Hermansky–Pudlak Syndrome (HPS) is a genetically heterogeneous disorder in which mutations in one of several
genes interrupts biogenesis of melanosomes, platelet dense bodies, and lysosomes. Affected patients have
oculocutaneous albinism, a bleeding diathesis, and sometimes develop granulomatous colitis or pulmonary ﬁ-
brosis. In order to assess the role of HPS genes in melanosome biogenesis, melanocytes cultured from patients
with HPS subtypes 1, 2, or 3 were assessed for the localization of various melanocyte proteins. Tyrosinase, Tyrp1,
and Dct/Tyrp2 were atypically and distinctly expressed in HPS-1 and HPS-3 melanocytes, whereas only tyrosinase
showed an atypical distribution in HPS-2 melanocytes. The HPS1 and AP3B1 (i.e., HPS-2) gene products showed no
expression in HPS-1 and HPS-2 melanocytes, respectively, whereas HPS-3 melanocytes exhibited normal expres-
sion for both proteins. In normal human melanocytes, the HPS1 protein was expressed as an approximately 80 kDa
molecule with both granular and reticular intracellular proﬁles. In HPS-1, lysosome associated membrane protein 1
(LAMP1), and LAMP3 were localized to abnormal large granules; in HPS-2, all LAMPs exhibited a normal granular
expression; and in HPS-3, LAMP1, and LAMP3 exhibited a distinct less granular and more ﬂoccular pattern. In
contrast, the expressions of Rab 27, transferrin, and cKit were unaffected in all three HPS genotypes. These data
demonstrate that the three initially identiﬁed subtypes of human HPS exhibit distinct defects in the trafﬁcking of
various melanocyte-specific proteins.
Key words: pigmentation/albinism/tyrosinase/lysosomes/translocation
J Invest Dermatol 124:420 –427, 2005
The biogenesis of functionally pigmented melanosomes is
complex and poorly understood, but a few elements of this
cellular process have been elucidated (Orlow, 1998; Raposo
and Marks, 2002). Numerous structural proteins, me-
lanogenic enzymes, and regulatory proteins need to be ac-
curately trafficked from their site of synthesis to their
melanosomal targets for efficient melanization to occur in
this distinct organelle (Marks and Seabra, 2001). Special-
ized protein complexes function in the selective recruitment
of melanosome-destined cargo at sites of synthesis, the
translocation of cargo vesicles toward the melanosomes,
either directly or via an intermediate organelle, and the ef-
ficient recognition, docking, fusion, and incorporation of
these specific cargo into the melanosomes. Elucidating
these trafficking molecules/chaperones in the melanocyte
has been a challenging endeavor.
Hermansky–Pudlak Syndrome (HPS [MIM203300]) is a
genetically heterogeneous, autosomal recessive disorder
that provides an experiment of nature for understanding
how trafficking molecules function in the biogenesis of
melanosomes. To date, seven genetic types of the HPS
have been identified in humans (Huizing et al, 2002; Li et al,
2003; Zhang et al, 2003) and approximately 15 genetically
distinct HPS models exist in mice (Swank et al, 1998; Huizing
et al, 2002). HPS presents with oculocutaneous albinism and
a bleeding diathesis (Hermansky and Pudlak, 1959; King
et al, 2001; Huizing et al, 2002). The albinism results from
the inability of cutaneous and ocular melanocytes to create
fully pigmented melanosomes due to mistrafficking of me-
lanogenic proteins (Huizing et al, 2002). The bleeding diathe-
sis results from the absence of dense bodies within platelets,
compromising clot formation (Witkop et al, 1987; Gahl et al,
1998). Some HPS patients develop lysosomal ceroid storage
(Bednar et al, 1964), granulomatous colitis (Schinella et al,
1980), or a fatal pulmonary fibrosis (Harmon et al, 1994;
Brantly et al, 2000). Each individual HPS gene is considered
to regulate a molecular aspect critical for the biosynthesis of
melanosomes, platelet dense bodies, and lysosomes.
HPS-1, HPS-2, and HPS-3 are the three genetic forms of
human HPS initially identified. The HPS1 gene was originally
mapped and isolated in a population of patients residing in
northwestern Puerto Rico (Wildenberg et al, 1995; Oh et al,
1996). HPS1 localizes to chromosome 10q23 and encodes
a predicted 79.3 kDa protein with no homology to known
proteins, although it contains a short segment predicted
to form coiled-coil structures (Oh et al, 1996). The HPS1
Abbreviations: HPS, Hermansky–Pudlak Syndrome; LAMP, lyso-
some associated membrane protein; NHM, normal human me-
lanocytes
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protein, whose function remains unknown, is distributed in
melanotic cells among uncoated vesicles, early-stage
melanosomes, and the cytoplasm as part of a large
complex of molecular weight  200 kDa in the cytoplasm
and 4500 kDa in a membrane-bound form (Oh et al, 2000).
Melanocytes from HPS-1 patients are hypopigmented and
exhibit unique membranous complexes with tyrosinase-
containing compartments (Boissy et al, 1998).
Mutations in the AP3B1 gene cause HPS-2 (Dell’Angelica
et al, 1999). AP3B1 is localized to chromosome 5q14.1 and
encodes the 140 kDa b3A-subunit of adaptor complex-3
(AP3) involved in vesicle/membrane formation and traffick-
ing (Dell’Angelica et al, 1997, 1998). Melanocytes from HPS-
2 patients are hypopigmented and exhibit sequestration
of tyrosinase to large endosome/multivesicular body-like
structures (Huizing et al, 2001b).
The HPS3 gene was initially identified in a central Puerto
Rican HPS isolate (Anikster et al, 2001) and subsequently in
other populations (Huizing et al, 2001a). HPS3 is located
on chromosome 3q24 and encodes a predicted 113.7 kDa
protein with no apparent homology to other proteins (An-
ikster et al, 2001; Suzuki et al, 2001). The HPS3 protein,
however, does contain a putative clathrin binding region
(Anikster et al, 2001), suggesting participation in intracellular
trafficking. We have recently demonstrated that 50 nm ves-
icles containing tyrosinase are extensively distributed
throughout HPS-3 melanocytes rather than being confined
to the trans-Golgi network as in normal human melanocytes
(NHM) (Boissy et al, 2004).
Specialized protein complexes function in series along
a cellular pathway for trafficking. Multimeric components
within these various complexes coordinate cargo recruit-
ment, vesicle budding, cytoskeletal interaction, target rec-
ognition, and vesicle fusion (Bonifacino and Glick, 2004).
HPS gene products are components of a group of com-
plexes termed BLOC (i.e., biogenesis of lysosome-related
organelles complexes) (Falcon-Perez et al, 2002; Chiang
et al, 2003; Ciciotte et al, 2003; Li et al, 2003; Martina et al,
2003; Gautam et al, 2004). BLOC facilitate the trafficking of
cargo to melanosomes, lysosomes, and platelet dense
bodies. But the molecular functions and sites of action of
BLOC remain unknown.
In this report, we compare the trafficking patterns of
various melanosomal proteins in melanocytes cultured from
patients with HPS-1, HPS-2, and HPS-3 to further charac-
terize the various pathways required for correct protein
trafficking and assembly of a functional melanosome. The
abnormal distribution patterns of proteins transported via
endolysosomal pathways distinguish these HPS subtypes
and implicate distinct sites of action for the three HPS gene
products.
Results
Expression of tyrosinase gene family proteins Me-
lanocytes from patients with HPS-1, HPS-2, and HPS-3
were evaluated by immunocytochemistry for the expression
pattern of tyrosinase gene family proteins [i.e., tyrosinase,
tyrosinase-related protein-1 (Tryp1), and DOPAchrome tau-
tomerase/tyrosinase-related protein-2 (Dct/Tyrp2)] (Fig 1). In
NHM, all three proteins exhibited intense staining around
the perinuclear area with marked granularity. Throughout
the lateral areas of the cell body and along the dendrites,
the staining remained granular but less dense. In HPS-1
melanocytes, in addition to this normal staining pattern, all
three proteins were localized to large granules distributed
predominantly throughout the cell body and occasionally
within the dendrites (Fig 1).
In HPS-2 melanocytes, tyrosinase was predominantly
restricted in its expression to the cell body with minimal
expression along the dendrites (Fig 1). In contrast, the lo-
calization patterns for both Tyrp1 and Dct/Tyrp2 appeared
normal, with marked expression in the dendrites (Fig 1). In
HPS-3 melanocytes, both tyrosinase and Tyrp1 exhibited an
expression pattern subtlety different from NHM. Although
expression of these proteins occurred in both the cell body
and dendrites, the pattern was less granular and more
Figure1
Melanocytes cultured from patients with Hermansky–Pudlak Syn-
drome (HPS)-1, HPS-2, and HPS-3 exhibit specific alterations in the
distribution of tyrosinase gene family members. Cultures of me-
lanocytes derived from an unaffected individual (normal human me-
lanocytes (NHM)) and from patients with HPS-1, HPS-2, or HPS-3 were
immunostained for tyrosinase, tyrosinase-related protein-1 (Tyrp1), or
DOPAchrome tautomerase/tyrosinase-related protein-2 (Dct/Tyrp2).
The NHM exhibited a granular staining pattern with prominent perinu-
clear localization for all three proteins. HPS-1 melanocytes exhibited a
similar granular staining pattern with additional large aggregates (ar-
rows) for all three proteins throughout the melanocytes. HPS-2 me-
lanocytes exhibited a relative restriction of tyrosinase to the cell body
with limited or no expression in the dendrites (arrowheads); Tyrp1 and
Dct/Tyrp2 exhibited normal expression patterns. HPS-3 melanocytes
displayed a floccular staining pattern within the cell body and dendrites
for tyrosinase, Tyrp1, and Dct/Tyrp2 expression. Scale bar¼ 10 mm.
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floccular compared with that in NHM (Fig 1). This differential
stain pattern in HPS-3 melanocytes was most noticeable
throughout the dendrites where the immunofluorescence
appeared more homogeneously distributed in HPS-3 me-
lanocytes and heterogeneous (i.e., granular) in NHM.
The co-localization of tyrosinase and Tyrp1 in large gran-
ules, characteristic of HPS-1 melanocytes, was quite het-
erogeneous (Figs 2a–c). Some large granules contained one
protein selectively, but more frequently a large granule con-
tained both proteins. Occasionally, tyrosinase and Tyrp1
exhibited discrete, separate areas of localization within the
granules, with partial overlap. As previously described, the
granules represent large membranous complexes contain-
ing melanosomes (Boissy et al, 1998). Dihydroxyphenylala-
nine (DOPA) histochemistry of HPS-1 melanocytes revealed
melanin reaction product in a subset of cisternae of the
membranous profiles and within some of the associated
melanosomes (Fig 2d), consistent with the heterogeneity in
localization of tyrosinase and Tyrp1 observed on light mi-
croscopy.
Expression of HPS gene family proteins Melanocytes
from patients with HPS-1, HPS-2, and HPS-3 were evalu-
ated by immunocytochemistry for expression of the HPS1
protein and the b3A and m3A subunits of AP3 (Fig 3). In
NHM, HPS1 showed a distinct perinuclear pattern with dra-
matically reduced expression along the dendrites (Fig 3).
HPS-2 and HPS-3 melanocytes exhibited a similar pattern of
expression. In contrast, HPS1 was absent from melanocytes
of HPS-1 patients bearing either the 16 base pair duplication
(Fig 3) or the S396 del C (not shown) mutations in HPS1.
The expression of the b3A and m3A subunits of AP3 in
NHM occurred with a distinct localized area in the cell body
(Fig 3). The m3A subunit exhibited a compact, tubular-net-
work profile, unilateral to the nucleus. In contrast, the b3A
subunit exhibited a more diffuse staining pattern, with a
more intense focus localized unilateral to the nucleus. Sim-
ilarly, HPS-1 and HPS-3 melanocytes displayed normal ex-
pression for both b3A and m3A (Fig 3). In contrast, HPS-2
melanocytes exhibited an absent or dramatically reduced
expression of b3A and the m3A, respectively.
Expression of the HPS1 protein in NHM was further
evaluated (Fig 4). Western blotting showed that HPS1 an-
tibodies recognized an approximately 80 kDa protein in
melanocytes derived from both a Caucasian and an African-
American donor; this protein was absent from melanocytes
of an HPS-1 patient (Fig 4a). In addition, the HPS1 anti-
bodies exhibited, by routine fluorescent microscopy, prom-
inent cell body staining with reduced dendritic staining in
NHM (Fig 4b) that was absent from HPS-1 melanocytes
(Fig 4c). Further analysis of HPS1 protein in NHM by con-
focal microscopy demonstrated prominent expression in
the perinuclear area of the cell body (Fig 4d) with a relative
reduction of staining in the Golgi area and the dendrites
(Fig 4d). The perinuclear staining appeared predominantly
granular (Fig 4d, arrows) with a reticular staining pattern
apparent among the granular profiles (Fig 4d, arrowheads).
Figure 2
Hermansky–Pudlak Syndrome (HPS)-1 melanocytes exhibit a var-
iation in co-localization of tyrosinase and tyrosinase-related pro-
tein-1 (Tyrp1) within characteristic large granules/membranous
complexes. In HPS-1 melanocytes, the characteristic large granules
(arrows) are positive for tyrosinase [red in (a)] and Tyrp1 [green in (b)].
The merged image (c) demonstrates that some large granules con-
tained tyrosinase only (arrow), some show equal co-localization of ty-
rosinase and Tyrp1 (inset #1), some display prominent co-localization of
tyrosinase and Tyrp1 with areas containing tyrosinase only (arrowhead,
inset #2), and some show polar expression of tyrosinase (arrowhead,
inset #3) and Tyrp1 (half-arrow) with an intervening area of co-locali-
zation. Electron microscopic evaluation of HPS-1 melanocytes treated
for DOPA histochemistry (d) demonstrates that, within a membranous
complex, some cisternae and melanosomes express (arrowheads) or
lack (arrows) reaction product, indicating the presence and absence of
tyrosinase, respectively. Scale bars¼10 (b) and 1.5 (d) mm.
Figure3
Melanocytes cultured from patients with Hermansky–Pudlak Syn-
drome (HPS)-1, HPS-2, and HPS-3 exhibit specific alterations in the
distribution of HPS gene products. Cultures of melanocytes derived
from an unaffected individual (normal human melanocytes (NHM)) and
patients with HPS-1, HPS-2, or HPS-3 were immunostained for HPS1
(HPS-p) and the b3A (beta3A) and m3A (mu3A) subunits of AP3. Ex-
pression of HPS1 protein (HPS1p) was similar in NHM, HPS-2 me-
lanocytes, and HPS-3 melanocytes but markedly diminished in HPS-1
melanocytes. Expressions of both b3A and m3A were normal in NHM,
HPS-1 melanocytes, and HPS-3 melanocytes but markedly diminished
in HPS-2 melanocytes. N, nucleus. Scale bar¼ 10 mm.
422 RICHMOND ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Expression of various melanocyte-expressed pro-
teins Melanocytes of patients with HPS-1, HPS-2, and
HPS-3 were evaluated by immunocytochemistry for the ex-
pression pattern of LAMP 1–3, Rab27, transferrin, and cKit
(Fig 5). In NHM, LAMP 1–3 exhibited a granular staining
pattern within the cell body and throughout the dendrites.
HPS-1 melanocytes exhibited normal localization for
LAMP2, but LAMP1 and LAMP3 showed additional expres-
sion in large granules similar to that observed for the tyros-
inase gene family members. HPS-2 melanocytes displayed
normal localization of LAMP 1–3. HPS-3 melanocytes
exhibited a floccular distribution pattern for LAMP1 and
LAMP3, similar to that observed for tyrosinase, Tyrp1, and
Dct/Tyrp2, and normal expression for LAMP2. Expression of
Rab27, transferrin, and cKit exhibited normal profiles in
melanocytes of the three HPS subtypes.
Discussion
The cellular pathways through which cargo proteins are di-
rected, from their site of synthesis to melanosomes, have
yet to be clearly delineated. The most prominent such car-
gos are the tyrosinase gene family proteins tyrosinase,
Tyrp1 and Dct/Tyrp2. Tyrosinase is a glycoprotein synthe-
sized in the rough endoplasmic reticulum that travels
through the Golgi for carbohydrate modification (Ujvari
et al, 2001; Francis et al, 2003; Watabe et al, 2004). Al-
though it is already enzymatically mature by the time it
reaches the trans-Golgi, tyrosinase has been shown with
DOPA histochemistry and electron microscopy to bud off
the trans-Golgi into vesicles that can be clathrin coated and
travel a short distance to premelanosomes (Novikoff et al,
1968; Maul, 1969; Maul and Brumbaugh, 1971). Tyrosinase
may also traffic through structures resembling multivesicu-
lar bodies en route to the premelanosome (Turner et al,
1976). Tyrp1 and Dct/Tyrp2 are also glycoproteins that
traverse the Golgi apparatus (Tsukamoto et al, 1992; Jime-
nez-Cervantes et al, 1994); Tyrp1 may also travel through an
organelle resembling a large multivesicular body (Orlow
Figure 4
The Hermansky–Pudlak Syndrome (HPS)1 protein is expressed in
normal human melanocytes (NHM) and absent in HPS-1 me-
lanocytes. (a) Lysates of cultured melanocytes derived from an HPS-1
patient with the 16 bp duplication (lane 1), a normal Caucasian (lane 2),
and a normal African/American (lane 3) individual were processed for
western blot analysis using HPS1 antiserum (upper blot) and actin an-
tibody (lower blot). A band of  80 kDa was present in both controls
and absent in the HPS-1 samples. Cultured melanocytes derived from
a Caucasian individual (b and d) and an HPS-1 patient with the 16 bp
duplication (c) were processed for indirect immunofluorescent cyto-
chemistry using HPS1 antiserum. Immunostaining as observed by rou-
tine fluorescent microscopy was present predominantly in the cell body
of control melanocytes (b) and absent in the HPS-1 melanocytes (c). As
observed by confocal microscopy (d), the staining pattern for the HPS-
1 protein in NHM was prominent in the perinuclear area of the cell body
(asterisk) with a relative reduction in staining in the Golgi area (G) and
the dendrites. The perinuclear staining appeared predominantly gran-
ular (arrows) with a reticular staining pattern (arrowheads) apparent
among the granular profiles. N, nucleus. Scale bars¼20 (c) and
7.5 (d) mm. Figure5
Melanocytes cultured from patients with Hermansky–Pudlak Syn-
drome (HPS)-1, HPS-2 and HPS-3 were evaluated for expression of
various proteins. Normal human melanocytes (NHM) and HPS-1,
HPS-2, or HPS-3 melanocytes were immunostained for LAMP 1–3, Rab
27, transferrin, and cKit. Expression of LAMP1 and LAMP3 was gran-
ular and that of LAMP2 was diffuse throughout the NHM. HPS-1 me-
lanocytes exhibited, in addition to the normal localization for LAMP 1–3,
localization to large granules (arrows) for LAMP1 and LAMP3. HPS-2
melanocytes exhibited normal localization for LAMP 1–3. HPS-3 me-
lanocytes exhibited a more floccular distribution pattern for LAMP1 and
LAMP3 and a normal distribution of LAMP2. Expression of Rab27,
transferrin, and cKit in NHM exhibited a uniform pattern throughout the
melanocytes with a distinct centriole localization (arrows), a punctate
pattern throughout the melanocytes, and a diffuse pattern throughout
the melanocytes, respectively. HPS-1, HPS-2, and HPS-3 melanocytes
exhibit a normal staining pattern for Rab27, transferrin, and cKit. Scale
bar¼20 mm.
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et al, 1993). It is unknown whether tyrosinase, Tyrp1, and
Dct/Tyrp2 travel together in the same or independent path-
ways to early-stage melanosomes, defined as containing
the melanofilament molecule Silver/Pmel17 (Berson et al,
2001, 2003).
Analysis of melanocytes cultured from patients with
HPS-1, HPS-2, and HPS-3 revealed a normal distribution
for proteins that do not reside in melanosomes (i.e., trans-
ferrin and cKit). In addition, a normal distribution was ob-
served for Rab27, a family of molecules that regulate
exocytosis of various cell-specific organelles (Izumi et al,
2003), in which Rab27a associates with the melanosome to
facilitate its transport to and capture at the terminal ends of
dendrites (Strom et al, 2002). In contrast, mutations in HPS1
and HPS3 did cause a distinctly aberrant localization of the
tyrosinase family proteins. In the absence of HPS1, the ty-
rosinase-related proteins, as well as LAMP1 and LAMP3,
were sequestered in large membranous complexes resem-
bling macroautophagosomes (Boissy et al, 1998).
Macroautophagy is a dynamic process involving rear-
rangement of subcellular membranes to sequester cyto-
plasm and organelles for delivery to the lysosome or
vacuole where the sequestered cargo is degraded and re-
cycled (Dunn, 1990; Seglen and Bohley, 1992; Klionsky and
Emr, 2000). The incorporation of tyrosinase, Tyrp1, and Dct/
Tyrp2 into macroautophagosomes in HPS-1 melanocytes
suggests that the HPS1 protein targets these cargos to
melanosomes, and the cargos move by default to macro-
autophagosomes when HPS1 is dysfunctional. Precedent
for such default pathways is provided by the mutant hunt-
ingtin protein, which becomes aberrantly localized to large
autophagosomes in Huntington’s disease (Kegel et al,
2000). In addition, the endogenous antigenic proteins pre-
sented by MHC class II traffic through autophagosomes
(Nimmerjahn et al, 2003).
Consistent with the role of HPS-1 in melanosomal tar-
geting of cargo is the ultrastructural localization of HPS1 to
the cytoplasmic face of melanosomes (Oh et al, 2000)
(Boissy, personal observation). HPS1 appears to be a pre-
dominantly cytosolic protein that can be associated with mem-
branes, possibly as a multimeric complex (Dell’Angelica
et al, 2000; Oh et al, 2000). HPS1 also appears to interact
with the HPS4 protein (Anderson et al, 2003) in a transient or
indirect manner (Suzuki et al, 2002) as part of the biogenesis
of lysosome-related organelles complex-3 (BLOC-3)
(Chiang et al, 2003; Martina et al, 2003).
Mutations in HPS3 also result in aberrant localization of
all three tyrosinase family members but with a different
distribution than what occurs in HPS-1 melanocytes. This
suggests distinct roles for the HPS3 and HPS1 proteins.
HPS-3 melanocytes exhibit a diffuse, less granular distri-
bution for the three tyrosinase gene family proteins, as well
as for LAMP1 and LAMP3. Recent evidence indicates that
tyrosinase is localized in 50 nm vesicles that are abnormally
scattered throughout the cell body and dendrites of HPS3
melanocytes (Boissy et al, 2004), as if by default of a normal,
HPS3-mediated pathway. This suggests that the HPS3 pro-
tein regulates the targeting of vesicles to a recipient site
and, in the absence of the HPS3 protein, these cargo ves-
icles are widely distributed throughout the cell body and
dendrites of the mutant cells. In addition, LAMP1 and
LAMP2 exhibit a greater perinuclear concentration in HPS-3
fibroblasts compared with normal cells and frequently fail to
extend into the cell periphery (Helip-Wooley et al, 2004). The
recognition step in trafficking regulated by HPS3 appears to
be independent of HPS1, since the morphologies of the two
HPS subtypes differ.
The HPS3 protein contains a putative clathrin binding
domain, a possible tyrosine phosphorylation site at codon
295, and several putative tyrosine-based sorting signals,
but no potential di-leucine sorting signals (Anikster et al,
2001) that could function in trafficking cargo. In normal
murine melanocytes, the HPS3 protein exhibits a cytoplas-
mic distribution and is not associated with the type 1 IP3
Figure 6
Model for involvement of Hermansky–Pudlak Syndrome (HPS1),
HPS2, and HPS3 in the trafficking of tyrosinase gene family
members from the Golgi to the melanosome. Tyrosinase, tyrosinase-
related protein-1 (Tyrp1), and DOPAchrome tautomerase/tyrosinase-
related protein-2 (Dct/Tyrp2) are recruited from the Golgi apparatus into
clathrin-coated vesicles to be trafficked along cytoskeletal element to
Stage II melanosomes in the perinuclear area. Biogenesis of lysosome-
related organelles complexes (BLOC)-2, composed in part of HPS3,
HPS5, and HPS6, facilitates this early cargo trafficking event. In the
absence of HPS3, cargo vesicles are aberrantly trafficked beyond the
perinuclear area. Tyrosinase, and possibly Tyrp1 and Dct/Tyrp2, transit
through multivesicular body (MVB)/late endosome-like structures on
route to melanosomes. Adaptin3 facilitates the recruitment of tyros-
inase from the MVB. In the absence of the b3A subunit of AP3, tyros-
inase is aberrantly retained in the MVB. Ultimately, vesicles containing
tyrosinase, Tyrp-1, and Dct/Tyrp2 recognize, dock, and fuse with Stage
II melanosomes. BLOC-3, composed in part of HPS1 and HPS4, fa-
cilitates this later cargo trafficking event. In the absence of HPS1, cargo
vesicles are aberrantly trafficked to macroautophagosomes.
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receptor, Rab3A, or the AP3 complex (Suzuki et al, 2001). In
NHM, the HPS3 protein interacts with clathrin (Helip-Wooley
et al, 2004), and may function in the BLOC-2 complex (Di
Pietro et al, 2004; Gautam et al, 2004) that also contains the
HPS5 and HPS6 proteins (Zhang et al, 2003).
In contrast to HPS1 and HPS3, the AP3B1 gene (asso-
ciated with HPS-2) affects only tyrosinase without any ap-
parent influence on the cellular distribution of Tyrp1 or Dct/
Tyrp2. AP3 is one of four adaptor complexes, i.e., het-
erotetrameric complexes involved in vesicle/membrane for-
mation and trafficking (Dell’Angelica et al, 1999; Robinson
and Bonifacino, 2001). Adaptor complexes play a role in the
formation of coated vesicles, as well as in the selection of
cargo for these vesicles. AP3 contains d, m3, and s3sub-
units, in addition to b3A. The known mutations in the AP3B1
gene cause loss of the b3A, destabilization of the d, m3, and
s3 subunits (Fig 3) (Huizing et al, 2001b), and thus loss of
functional AP3. The b3A subunit binds clathrin, whose rigid
triskelion structure causes outpouching from an existing
membrane (Dell’Angelica et al, 1998). In addition, AP3 con-
tains putative di-leucine and tyrosine-based signal motifs
for sorting in the b3A and the m3A subunits, respectively
(Robinson and Bonifacino, 2001). Tyrosinase interacts with
AP3 via its di-leucine motif (Honing et al, 1998) and is re-
tained in multivesicular body/late endosome-like structures
in HPS-2 melanocytes (Huizing et al, 2001b). Apparently,
neither Tyrp1 nor Dct/Tyrp2 express the requisite di-leucine
motif required to bind AP3, accounting for their normal dis-
tribution in HPS-2 melanocytes. In contrast, AP3B1 gene
mutations result in impaired trafficking of tyrosinase to
melanosomes. HPS-2 fibroblasts also traffic LAMP 1–3
through the plasma membrane in an enhanced fashion,
suggesting that the plasma membrane provides a default
pathway that operates when normal AP3 function is
blocked in this cell type (Dell’Angelica et al, 1999). This de-
fault pathway does not appear to occur in HPS-2 me-
lanocytes, suggesting that an AP3-independent route via
the plasma membrane is not an alternate for tyrosinase in
melanocytes.
Taken together, these data suggest that the gene prod-
ucts of HPS1, AP3, and HPS3 regulate distinctly different
steps in the trafficking pathway for tyrosinase gene family
proteins from the Golgi to melanosomes. This proposed
assessment for the cellular roles of these proteins is based
primarily on morphologic data; however, biochemical anal-
ysis is required to substantiate this model. The HPS1 pro-
tein is essential for the accurate deposition of these proteins
to the melanosomes. In the absence of HPS1, tyrosinase,
Tyrp1, and Dct/Tyrp2 are trafficked to macrophagosomes,
presumably for default degradation. The HPS1 protein is
primarily a cytosolic protein that can be associated with the
limiting membrane of the melanosome (Oh et al, 2000)
(Boissy, personal observations). This positions HPS1, along
with its partner HPS4, at the recognition/docking/fusion in-
terface between incoming cargo vesicles and melanosomes
(Fig 6). The HPS3 protein also regulates the accurate traf-
ficking of tyrosinase gene family members to melanosomes.
As described above, however, the HPS3-regulated step is
distinct from that regulated by the HPS1/HPS4 complex.
We propose that HPS3, along with its complex partners
HPS5 and HPS6, functions upstream of HPS1/HPS4 (Fig 6).
In contrast, the protein defective in HPS-2 (i.e., the b3A
subunit of AP3) regulates the trafficking of tyrosinase only.
We propose that this selective step occurs within an endo-
some/multivesicular-like sorting body used for transit be-
tween the Golgi and melanosomes (Fig 6). It is uncertain
whether Tyrp1 and Dct/Tyrp2 travel through a similar inter-
mediate compartment and whether they use an alternate
adaptor-like molecule to do so. In addition, it is uncertain
whether Tyrp1 and Dct/Tyrp2 are sorted through similar or
distinct pathways with respect to each other.
The comparative analysis of the patterns of melanocyte
protein distribution in HPS-1, HPS-2, and HPS-3 described
herein provides a glimpse into the elaborate mechanism
responsible for targeting cargo from the Golgi apparatus to
melanosomes. Some HPS molecules regulate trafficking of
tyrosinase gene family members coordinately en route to
the melanosomes, whereas other HPS molecules assist the
trafficking of selective melanocyte proteins. Melanin syn-
thesis generates several toxic intermediates. Segregation of
tyrosinase gene family members during post-translational
translocation may be important to prevent inappropriate
melanization from occurring in non-melanosomal structures
prior to accumulation in the melanosomal microdomain.
Materials and Methods
Cell culture Cultures of melanocytes were developed from neo-
natal foreskins or skin biopsies. Normal human neonatal foreskins
(from African/American and Caucasian infants) were obtained
from the nursery of University Hospital in Cincinnati after routine
circumcision using a protocol approved by the University of
Cincinnati Institutional Review Board. Three HPS-1 patients, two
HPS-2 patients, and three HPS-3 patients were enrolled in a pro-
tocol approved by the National Institute of Child Health and Human
Development and the National Human Genome Research Institute
Institutional Review Boards to study the clinical and molecular as-
pects of HPS. All procedures for obtaining human tissue were
conducted according to Declaration of Helsinki principles. Patient
numbers corresponded to those of a master list of enrolled sub-
jects. Two of the HPS-1 patients were homozygous for the 16 base
pair duplication and one for the S396 del C mutation in the HPS1
gene. The two HPS-2 patients were brothers and compound het-
erozygous for a 63 base pair deletion and an L580R mutation in the
b3A gene (Dell’Angelica et al, 1999). Two of the three HPS-3 pa-
tients were homozygous for a 3.9 kb deletion encompassing exon
1 of the HPS3 gene, and the third HPS-3 patient was compound
heterozygous for the 3.9 kb deletion and a I243insA. After written
informed consent was obtained, a 4 mm punch biopsy was taken
from each patient, and half was placed immediately in melanocyte
growth medium with 2  antibiotic/antimycotic solution and
shipped by express mail to Cincinnati, Ohio. All skin samples
were placed in trypsin (2.5 mg per L) and incubated for 2 h at 371C.
The trypsin was replaced with MCDB-153 medium, and the tissue
was gently vortexed for 30 s to separate the dermis as a single
piece and to produce an epidermal cell suspension. The epidermal
cells were seeded in a T-25 cm2 flask (for foreskins) or a 2 cm2 well
(for skin biopsies) in MCDB-153 medium (Irvine Scientific, Santa
Anna, California) as previously described (Medrano and Nordlund,
1990). The MCDB-153 growth medium was supplemented with
0.6 ng per mL basic fibroblast growth factor, 8 nM 12-O-tetrad-
ecanoylphorbol-13-acetate (TPA), 5 mg per mL insulin, 5 mg per mL
transferrin, 1.0 mg per mL a-tocopherol, 30 mg per mL crude pi-
tuitary extract (Clonetic Laboratories, San Diego, California), 0.5 mg
per mL hydrocortisone, 20 mg per mL catalase from bovine liver,
and 10% heat-inactivated fetal calf serum. Cultures were fed
with fresh medium twice weekly. Catalase was omitted from the
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medium after Day 6. Fibroblasts were eliminated by incubating
cultures for 3–4 d in the presence of 100 mg per mL geneticin (G418
sulfate) (Halaban and Alfano, 1984). Cultures from the second to
the fifth passage were used for the experiments described herein.
Immunoﬂuorescent microscopy Established cultures of me-
lanocytes, maintained in regular MCDB-153 growth media, were
plated on gelatin-coated Lab-Tek (Nunc, Naperville, Illinois) cham-
ber slides at 2.5  104 cell per 0.9 cm2 well and processed for
indirect immunofluorescence the next day. The cells were fixed in
2% formaldehyde in phosphate-buffered saline (PBS) for 10 min at
room temperature, blocked in 1% bovine serum albumin (BSA) in
PBS for 5 min at room temperature, and incubated in primary an-
tibody solution diluted in 0.2% Saponin in PBS containing 0.1%
BSA for 60 min at room temperature. The primary antibodies used
in this study included rabbit polyclonal antiserum to tyrosinase
provided by R. King and W.S. Oetting (hPEP1; University of Min-
nesota, Minneapolis) (1:300), mouse monoclonal antiserum to
Tyrp1 (Mel-5; Signet Laboratories, Dedham, Massachusetts),
(1:50), rabbit polyclonal antiserum to Dct/Tyrp2 provided by V.
Hearing (PEP8; National Institutes of Health), (1:200), mouse
monoclonals antisera to LAMP1 (H4A3), LAMP2 (H4B4), and
LAMP3 (H5C6) (Developmental Studies Hybridoma Bank (Iowa
City, Iowa) (1:300), rabbit polyclonal antiserum to the HPS1 protein
(Dell’Angelica et al, 2000) (1:300), rabbit polyclonal antisera to b3A
and m3A provided by M. S. Robinson (Cambridge Institute for
Medical Research, Cambridge, Great Britain) (both 1:300), rabbit
polyclonal antiserum to Rab27 (610595; BD Transduction Labora-
tories, Lexington, Kentucky) (1:300), rabbit polyclonal antiserum to
transferrin (0061; Dako, Santa Barbara, CA) (1:300), and mouse
monoclonal antiserum to c-Kit (CD117; Novocastra Laboratories,
Newcastle upon Tyne, UK) (1:50). Cells were then washed and
incubated in secondary antibody solution diluted in 0.2% Saponin
in PBS containing 0.1% BSA for 60 min at room temperature. The
secondary antibodies consisted of Cy-2-conjugated donkey anti-
mouse and Cy-3-conjugated donkey anti-rabbit (Jackson Immuno-
research, West Grove, Pennsylvania). After washing, coverslips
were applied to the slides using Fluoromount G (Southern Bio-
technologies, Birmingham, Alabama) and observed and digitally
photographed with either a Leitz (Rockleigh, New Jersey) Dialu
Fluorescent microscopy or a Zeiss (Thornwood, New York) LSM
510 confocal microscope.
DOPA histochemistry and electron microscopy Established
cultures of HPS-1 melanocytes, maintained in regular MCDB-153
growth medium, were seeded into Lab-Tek chamber slides (Nunc)
coated with 1% pig gelatin, and grown to 90% confluence. Cul-
tured melanocytes were fixed in wells with half-strength Karnov-
sky’s fixative (Karnovsky, 1965) in 0.2 M sodium cacodylate buffer
at pH 7.2 for 30 min at room temperature. For DOPA histochem-
istry, fixed cells were incubated in a 0.1% solution of L-DOPA twice
for 2.5 h. The cells were washed three times in buffer and treated
with 1.0% osmium tetroxide containing 1.5% potassium ferrocy-
anide (Karnovsky, 1971) for 30 min. The cells were washed, stained
en bloc with 0.5% uranyl acetate for 30 min, dehydrated, and em-
bedded in Eponate 12. Areas of the Epon cast were cut out and
mounted on Epon pegs and sectioned on an RMC MT 6000-XL
ultramicrotome. Ultrathin sections were then stained with aqueous
solutions of uranyl acetate (2%) and lead citrate (0.3%) for 15 min
each and then viewed and digitally photographed in a ZEOL 1230
transmission electron microscope. (All tissue-processing supplies
were purchased from Ted Pella, Tustin, California.)
Western blot analysis Total cellular proteins, from an NHM line
and a line of melanocytes derived from a patient with HPS-1 (ho-
mozygous for a 16-base pair duplication in HPS1), were extracted
using RIPA buffer. Equal amounts of protein were fractionated on a
10% sodium dodecyl sulfate polyacrylamide gel. The proteins were
transferred to a nitrocellulose membrane and incubated with 10%
non-fat dry milk in PBS and Tween-20 (PBST, pH 7.4 with 0.2%
Tween-20) for 1 h at room temperature. The membrane was
probed with the rabbit polyclonal antiserum to the HPS1 protein
(Dell’Angelica et al, 2000) (1:1000) or a monoclonal antibody to
actin (Santa Cruz Biotechnology, Santa Cruz, California) (1:500).
Primary antiserum/antibody was diluted in 2% nonfat milk/PBST
and incubated at 41C for 3 h. The bands of interest were visualized
by indirect immuno-enzymatic staining using an alkaline phospha-
tase-labeled secondary antiserum followed by BCIP/NBTsubstrate
(Kirkegaard and Perry, Gaithersburg, Maryland).
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